Search - tctmd.com

Displaying 801 - 820 of 1213

Sort: Relevancy | Date

Presentation TCT 2014

Cath Lab Evolution: Imaging Integration, Radiation Reduction, and Beyond

Presenter: Charles E. Chambers

September 15, 2014

Presentation TCT 2014

Clinician Perspective

Presenter: James A. Goldstein

September 15, 2014

Presentation TCT 2014

Keynote Lecture I: The New FDA-CDRH: Lessons Learned, Current Challenges, and Future Vision

Presenter: Matthew G. Hillebrenner, Martin B. Leon, Aaron V. Kaplan, William H. Maisel

September 15, 2014

Presentation TCT 2014

Physicist Perspective

Presenter: Stephen Balter

September 15, 2014

Presentation TCT 2014

TCT 614: Detailed Morphologic Characterization of the Strut Composition Following Absorb Scaffold Placement in a Porcine Coronary Artery Model Through 48 Months

Presenter: David P. Faxon, Fumiyuki Otsuka, MD

September 15, 2014

Presentation TCT 2014

Perspective from CMS and CMMI

Presenter: Jack C. Lewin, Patrick Conway

September 15, 2014

Presentation TCT 2014

Perspective on the Impact of Health Reform on Business, Consumers, and Providers: The National Coalition on Health Care

Presenter: Jack C. Lewin, John Rother

September 15, 2014

Presentation TCT 2014

TCT 102: Incidence of Angina and Chest Pain Following Percutaneous Coronary Intervention: A Retrospective Analysis Using Administrative Claims Data in the United States

Presenter: David P. Faxon, Ori Ben-Yehuda

September 15, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Chris Kwok Yiu Wong, Alan C. Yeung, Robaayah Zambahari, Quang Ngoc Nguyen

September 15, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Chris Kwok Yiu Wong, Alan C. Yeung, Robaayah Zambahari, Reginald I. Low

September 15, 2014

Presentation TCT 2014

Case #4: Massive Coronary Perforation with No Stent Grafts in the Lab

Presenter: Chris Kwok Yiu Wong, Alan C. Yeung, Robaayah Zambahari, Quang Ngoc Nguyen

September 15, 2014

Presentation TCT 2014

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Presenter: Dirk Sibbing

September 14, 2014

Presentation TCT 2014

Yes: TRA-2P Has Proven it!

Presenter: David J. Moliterno

September 14, 2014

Presentation TCT 2014

NO: Cangrelor Is No Champion Next to the Appropriate Use of Potent Oral Antiplatelet Agents!

Presenter: Dimitrios Alexopoulos

September 14, 2014

Presentation TCT 2014

YES: CHAMPION PHOENIX was Convincing!

Presenter: Deepak L. Bhatt

September 14, 2014

Presentation TCT 2014

Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well!

Presenter: Harvey D. White

September 14, 2014

Presentation TCT 2014

TCT 14: Preventive Versus Culprit-Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta-analysis

Presenter: Yeo-Jeong Song, MD

September 14, 2014

Presentation TCT 2014

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

Presenter: Frank Litvack, Todd J. Brinton

September 14, 2014

Presentation TCT 2014

NO: Too Small a Trial, Too Much Uncertainty!

Presenter: Ran Kornowski

September 14, 2014

Presentation TCT 2014

YES: PRAMI Proved This - Time to Change the Guidelines!

Presenter: Keith G. Oldroyd

September 14, 2014

Advertisement

Cath Lab Evolution: Imaging Integration, Radiation Reduction, and Beyond

Clinician Perspective

Keynote Lecture I: The New FDA-CDRH: Lessons Learned, Current Challenges, and Future Vision

Physicist Perspective

TCT 614: Detailed Morphologic Characterization of the Strut Composition Following Absorb Scaffold Placement in a Porcine Coronary Artery Model Through 48 Months

Perspective from CMS and CMMI

Perspective on the Impact of Health Reform on Business, Consumers, and Providers: The National Coalition on Health Care

TCT 102: Incidence of Angina and Chest Pain Following Percutaneous Coronary Intervention: A Retrospective Analysis Using Administrative Claims Data in the United States

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #4: Massive Coronary Perforation with No Stent Grafts in the Lab

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Yes: TRA-2P Has Proven it!

NO: Cangrelor Is No Champion Next to the Appropriate Use of Potent Oral Antiplatelet Agents!

YES: CHAMPION PHOENIX was Convincing!

Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well!

TCT 14: Preventive Versus Culprit-Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta-analysis

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

NO: Too Small a Trial, Too Much Uncertainty!

YES: PRAMI Proved This - Time to Change the Guidelines!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content